The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Tambocor 50 mg Tablets

50 milligram(s) Tablet

Mylan IRE Healthcare LimitedPA2010/026/002

Main Information

Trade NameTambocor 50 mg Tablets
Active SubstancesFlecainide acetate
Strength50 milligram(s)
Dosage FormTablet
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/026/002

Group Information

ATC CodeC01BC Antiarrhythmics, class Ic
C01BC04 flecainide

Status

Authorised/WithdrawnAuthorised
Licence Issued01/10/1999
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back